Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West Africa

NCT06860178 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40000

Enrollment

OTHER

Sponsor class

Conditions

Malaria Vaccine

Interventions

OTHER: Annual campaign of the 3-dose primary series vaccine R21/Matrix-M aligned with SMC distribution in children aged 3-59 months

Sponsor

Epicentre

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]